Phase II therapeutic equivalence study of Abiraterone Acetate Tablets (I) vs. ZYTIGA (R) in patients with metastatic castration-resistant prostate cancer.

Ye, DW; Bian, XJ; Han, WQ; Bin Wu; Chen, H; Wu, J; Yu, DX; Ge, HX; Li, J; Huang, HB; Fan, TW; Cheng, LZ; Zhang, XP; Zhang, XP; Yao, X; Wei, JL; Xu, ZQ; Mu, PL; Huang, R; Wang, H

JOURNAL OF CLINICAL ONCOLOGY, 2022; 40 (16): E17040

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索